BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20171211T120000
DTEND;TZID=America/New_York:20171211T130000
DTSTAMP:20260419T214816
CREATED:20170918T194500Z
LAST-MODIFIED:20190307T185749Z
UID:10000923-1512993600-1512997200@www.med.unc.edu
SUMMARY:McAllister Heart Institute Seminar Series: Kristy Red-Horse\, PhD. Coronary Artery Development
DESCRIPTION:Speaker: Kristy Red-Horse\, PhD\, Assistant Professor\, Department of Biology\, Stanford UniversityTopic: Coronary Artery Development: Transcriptional Regulation of Blood Flow Guided Behaviors
URL:https://www.med.unc.edu/medicine/event/mcallister-heart-institute-seminar-series-kristy-red-horse-phd/
CATEGORIES:Medicine Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20171214T120000
DTEND;TZID=America/New_York:20171214T130000
DTSTAMP:20260419T214816
CREATED:20171214T170000Z
LAST-MODIFIED:20190307T185639Z
UID:10000846-1513252800-1513256400@www.med.unc.edu
SUMMARY:Medicine Grand Rounds\, Rumey Ishizawar "Autoimmunity Induced by Cancer Immunotherapy"
DESCRIPTION:Immune-related adverse events are an unintentional side effect of immune checkpoint inhibitors used for cancer immunotherapy. Immune checkpoint inhibitors upregulate the immune system to prevent tumor evasion and promote destruction of tumor cells. These immune checkpoint inhibitors are effective as noted by the expanding number of FDA-approved drugs in this class and number of indications. In upregulating the immune system to target tumor cells\, these immune checkpoint inhibitors can tip the balance of the immune system to overreact against normal cells\, leading to presentations similar to autoimmune diseases. Emergence of immune-related adverse events can provide insight to rare autoimmune diseases. \nRumey Ishizawar is an assistant professor of Medicine and the medical director of the Rheumatology Specialty Clinic. She is developing an autoimmunity database\, studying oncology patients that develop immune-related adverse events. The immune-oncology patient registry will promote clinical\, translational and basic research.
URL:https://www.med.unc.edu/medicine/event/dec-14/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/rumey-ishizawar.jpeg
END:VEVENT
END:VCALENDAR